As free cholesterol in cell membranes facilitates the immune response of T cells, inhibition of ACAT using avasimibe shows profound efficacy in reducing tumor progression with or without anti-PD-1 therapy [59] (Table 2). This evidence concerns the gene ACAT1 and neoplasm.